Stage-specific inhibition of mammary carcinogenesis by 1alpha-hydroxyvitamin D5.
Mehta
Rajendra G
RG
Department of Surgical Oncology, College of Medicine, University of Illinois, 840 S Wood Street (M/C 820), Chicago, IL 60612, USA. raju@uic.edu
D000818:Animals; D016588:Anticarcinogenic Agents / Q000627:therapeutic use*; D005260:Female; D006887:Hydroxycholecalciferols / Q000627:therapeutic use*; D008325:Mammary Neoplasms, Experimental / Q000139:chemically induced / Q000517:prevention & control*; D011230:Precancerous Conditions / Q000139:chemically induced / Q000517:prevention & control*; D051381:Rats; D017207:Rats, Sprague-Dawley; D014407:Tumor Cells, Cultured
C103958:1-hydroxyvitamin D5; D016588:Anticarcinogenic Agents; D006887:Hydroxycholecalciferols